Latimer Jean J, Nazir Tariq, Flowers Lisa C, Forlenza Michael J, Beaudry-Rodgers Kelly, Kelly Crystal M, Conte Julie A, Shestak Kenneth, Kanbour-Shakir Amal, Grant Stephen G
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Exp Cell Res. 2003 Nov 15;291(1):111-21. doi: 10.1016/s0014-4827(03)00368-9.
DNA repair is essential for the maintenance of genomic integrity and stability. Nucleotide excision repair (NER) is a major pathway responsible for remediation of damage caused by UV light, bulky adducts, and cross-linking agents. We now show that NER capacity is differentially expressed in human tissues. We established primary cultures of peripheral blood lymphocytes (PBLs: N = 33) and foreskin fibroblasts (FF: N = 6), as well as adult breast tissue (N = 22) using a unique culture system, and measured their NER capacity using the unscheduled DNA synthesis (UDS) functional assay. Relative to FF, primary cultures of breast cells exhibited only 24.6 +/- 2.1% of NER capacity and PBLs only 8.9 +/- 1.2%. Cells from the breast therefore have a unique and distinctive DNA repair capacity. The NER capacities of all three cell types had similar coefficients of variation in the range of 10%-15%, which should be taken into account when running controls for this contextual assay. Unlike previous studies and speculation in the field, we found that NER was not affected by cell morphology, donor age, or proliferation as measured by the S phase index. While the NER capacity of the transformed lymphoblastoid cell line TK6 was within the range of our PBL samples, the breast tumor-derived MDA MB-231 cell line was four-fold higher than normal breast tissue. These studies show that analysis of baseline DNA repair in normal human cell types is critical as a basis for evaluation of the effects of "mutator" genes as etiological factors in the development of cancer.
DNA修复对于维持基因组完整性和稳定性至关重要。核苷酸切除修复(NER)是负责修复由紫外线、大分子加合物和交联剂造成损伤的主要途径。我们现在表明,NER能力在人体组织中存在差异表达。我们使用独特的培养系统建立了外周血淋巴细胞(PBLs:N = 33)、包皮成纤维细胞(FF:N = 6)以及成人乳腺组织(N = 22)的原代培养物,并使用非预定DNA合成(UDS)功能测定法测量它们的NER能力。相对于FF,乳腺细胞原代培养物的NER能力仅为24.6 +/- 2.1%,而PBLs仅为8.9 +/- 1.2%。因此,乳腺细胞具有独特且与众不同的DNA修复能力。所有三种细胞类型的NER能力具有相似的变异系数,范围在10% - 15%之间,在进行此背景测定的对照时应予以考虑。与该领域先前的研究和推测不同,我们发现NER不受细胞形态、供体年龄或通过S期指数测量的增殖的影响。虽然转化的淋巴母细胞系TK6的NER能力在我们的PBL样本范围内,但源自乳腺肿瘤的MDA MB - 231细胞系比正常乳腺组织高四倍。这些研究表明,分析正常人类细胞类型中的基线DNA修复对于评估“突变”基因作为癌症发生病因因素的影响至关重要。